BHEL, Hyundai & more: Top stocks on brokers’ radar today

Equirus downgraded Protean eGovernance due to losing a key government project, impacting revenue significantly. Jefferies maintains a hold on Divis Laboratories, citing patent challenges and valuation. Kotak has a sell rating on BHEL due to weak execution. CLSA is positive on Hyundai Motors India, while Morgan Stanley downgraded HAL due to concerns about execution guidance.

More From Author

<div>Abhishek Sharma Breaks Silence On Heated Spat With Lucknow Super Giants Star: “Spoke To Him…”</div>

<div>Ravi Shastri Explains Virat Kohli’s Test Retirement: “Would’ve Been Good To Hand Him Captaincy”</div>

Leave a Reply

Your email address will not be published. Required fields are marked *